Puma Exploration Arranges $5,000,000 Private Placement and Announces The Appointment of Mia Boiridy as The Head of Investor Relations and Corporate Development – Insidexploration
PUMA® - PUMA Investor Relations
PUMA® - PUMA Investor Relations
PUMA® - PUMA Investor Relations
PUMA® - PUMA releases preliminary results for the fourth quarter and financial year 2021
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire